Pediatric NonAlcoholic Fatty Liver Disease (NAFLD)

Are you evaluating a pediatric patient?

Yes

Gender of the patient

Male

Female

Is/Does the patient ...

• obese or overweight?

Yes

• have insulin resistance or type 2 diabetes mellitus?

Yes

• have elevated serum lipids (cholesterol triglycerides)?

Yes

• have hypertension?

Yes

• have a persistent elevation of liver function tests (GGT ALT AST) for which there is no explanation?

Yes

• Hispanic?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of reasons to suspect that the patient may be at risk for NAFLD

Should you evaluate the patient for NAFLD?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Laboratory Tests
Other Testing
- Grading and Staging Scheme for Nonalcoholic Steatohepatitis
Criteria For Diagnosis
- NAFLD Fibrosis Score
Severity, Prognosis, Stage
Complications
- Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatic Fibrosis
Differential Diagnosis And Mimics, Red Flags
- Model for Distinguishing Nonalcoholic Steatohepatitis (NASH) from Cryptogenic Chronic Hepatitis

Therapy

Options
- Predictors of Angulo et al for Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
Prevention
- Predictors of Angulo et al for Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis

Monitoring

Disease Progression
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score (NAS) of Kleiner et al
- Modified Criteria for Histologic Scoring of Nonalcoholic Steatohepatitis
Complication Detection
- Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatic Fibrosis

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10

Pediatric Non Alcoholic Fatty Liver Disease (NAFLD)

Purpose: To identify a pediatric patient who may be at risk for non-alcoholic fatty liver disease (NAFLD).

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10